Web Exclusives

Compared with Noncancer Controls, Breast Cancer Survivors Reported More Problems with Cognition, Sexual Function, Fatigue, and Anxiety

Evidence from studies indicates that common genetic and epigenetic features of male and female breast cancer are not shared, but further studies are warranted. Read More ›

Trends in Pathologic Complete Response After Treatment with Neoadjuvant Chemotherapy for Breast Cancer Among Racial Minority Groups

Breast cancer survivors should be closely monitored and offered appropriate evidence-based treatment for fatigue, cognitive dysfunction, and sexual problems. Read More ›

Examining the Potential Role of Chronic Inflammatory Processes in Breast Cancer Development

An analysis of racial minority groups treated for breast cancer demonstrates worse survival outcomes. Read More ›

Sotorasib Demonstrates Clinical Benefit in Patients with NSCLC Harboring KRASᴳ¹²ᶜ

Breast cancer’s initiation, progression, and behavior may be affected by chronic inflammation. Read More ›

Lung Cancer Incidence in the United States Declines Among All Patient Subgroups

In recently released study results of the phase 2 CodeBreaK 100 trial, sotorasib demonstrated a response rate across all trial subgroups. Read More ›

Severe Adverse Events from Immune Checkpoint Inhibitor Therapy Are Rare

Lung cancer incidence rates have declined due to a decrease in risk factors and improved screening and treatment. Read More ›

Retrospective Study Results Demonstrate Lung Imaging Pattern Differences Among Cancer Types

Immune checkpoint inhibitors cause rare severe adverse events in patients, but most patients improve with treatment. Read More ›

Using Prescreening as a Means of Increasing Oncology Trial Enrollment

Patients with NSCLC harboring KRAS G12C have distinct imaging patterns from patients with other NSCLC genetic mutations. Read More ›